Zoetis Inc. (NYSE:ZTS) is named one of the 14 Best Pharma Dividend Stocks to Buy in 2025. The company is a key player in the animal health sector, known for its innovative products like Solensia and Librela. Zoetis reported strong performance in Q1 2025, with revenue exceeding analyst estimates by $27.09 million.

Zoetis Inc. (NYSE:ZTS) has a solid track record of raising dividends for 14 consecutive years, with a low payout ratio of nearly 30%. It has increased payouts at an annual average rate of over 20% in the past five years. The company currently offers a quarterly dividend of $0.50 per share and has a dividend yield of 1.33%.

While Zoetis (ZTS) shows promise, some AI stocks may offer higher potential returns with lower risks. Investors seeking undervalued AI stocks can explore opportunities in companies benefiting from Trump-era tariffs and onshoring trends. For more information, a free report on the best short-term AI stock is available.

No promotional or marketing information included in this report.

Read more at Yahoo Finance: Is Zoetis (ZTS) a Unique Dividend Play in the Pharma Space for 2025?